Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10282529" target="_blank" >RIV/00216208:11110/14:10282529 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064165:_____/14:10282529
Výsledek na webu
<a href="http://dx.doi.org/10.1053/j.ajkd.2013.12.013" target="_blank" >http://dx.doi.org/10.1053/j.ajkd.2013.12.013</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1053/j.ajkd.2013.12.013" target="_blank" >10.1053/j.ajkd.2013.12.013</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
Popis výsledku v původním jazyce
The relevance of the cause of kidney disease to prognosis among patients with chronic kidney disease is uncertain. Study Design: Observational study. Settings & Participants: 6,245 nondialysis participants in the Study of Heart and Renal Protection (SHARP). Predictor: Baseline cause of kidney disease was categorized into 4 groups: cystic kidney disease, diabetic nephropathy, glomerulonephritis, and other recorded diagnoses. Outcomes: End-stage renal disease (ESRD; dialysis or transplantation) and death.Results: During an average 4.7 years' follow-up, 2,080 participants progressed to ESRD, including 454 with cystic kidney disease (23% per year), 378 with glomerulonephritis (10% per year), 309 with diabetic nephropathy (12% per year), and 939 with otherrecorded diagnoses (8% per year). By comparison with patients with cystic kidney disease, other disease groups had substantially lower adjusted risks of ESRD (relative risks of 0.28 [95% CI, 0.24-0.32], 0.40 [95% CI, 0.34-0.47], and 0.29
Název v anglickém jazyce
Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
Popis výsledku anglicky
The relevance of the cause of kidney disease to prognosis among patients with chronic kidney disease is uncertain. Study Design: Observational study. Settings & Participants: 6,245 nondialysis participants in the Study of Heart and Renal Protection (SHARP). Predictor: Baseline cause of kidney disease was categorized into 4 groups: cystic kidney disease, diabetic nephropathy, glomerulonephritis, and other recorded diagnoses. Outcomes: End-stage renal disease (ESRD; dialysis or transplantation) and death.Results: During an average 4.7 years' follow-up, 2,080 participants progressed to ESRD, including 454 with cystic kidney disease (23% per year), 378 with glomerulonephritis (10% per year), 309 with diabetic nephropathy (12% per year), and 939 with otherrecorded diagnoses (8% per year). By comparison with patients with cystic kidney disease, other disease groups had substantially lower adjusted risks of ESRD (relative risks of 0.28 [95% CI, 0.24-0.32], 0.40 [95% CI, 0.34-0.47], and 0.29
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FE - Ostatní obory vnitřního lékařství
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
American Journal of Kidney Diseases
ISSN
0272-6386
e-ISSN
—
Svazek periodika
64
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
9
Strana od-do
40-48
Kód UT WoS článku
000338938500010
EID výsledku v databázi Scopus
—